Figure 1.
CONsolidated Standards of Reporting Trials diagram showing the selection of subjects from Early Detection Research Network (EDRN) cohort. Subjects underwent bronchoscopy with bronchoalveolar lavage (BAL) at baseline. After bronchoscopy, subjects were randomised to either placebo or azithromycin for 8 weeks. Post-treatment bronchoscopy was performed at the end of the treatment period. BAL was used to evaluate microbiome (16S), metabolome and inflammation. NYU, New York University.